Related Experiment Video

Updated: Nov 4, 2025

Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity
06:39

Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity

Published on: September 1, 2023

3.4K

The clinical role of host and bacterial-derived extracellular vesicles in pneumonia

Anna Lena Jung1, Bernd Schmeck2, Marie Wiegand1

  • 1Institute for Lung Research, Universities of Giessen and Marburg Lung Center, Philipps University Marburg, Marburg, Hesse, Germany.

Advanced Drug Delivery Reviews
|May 22, 2021
PubMed

Insights

Extracellular vesicles (EVs) play a key role in host-pathogen interactions during pneumonia. Understanding these roles could lead to new vaccines and therapies for this deadly respiratory disease.

Area of Science:

  • Microbiology
  • Immunology
  • Cell Biology

Background:

  • Pneumonia remains a leading cause of global morbidity and mortality.
  • Drug resistance and emerging pathogens pose significant healthcare challenges.
  • Understanding host-pathogen interactions is crucial for developing novel control strategies.

Purpose of the Study:

  • To review the role of extracellular vesicles (EVs) in host-pathogen interactions in pneumonia.
  • To discuss evidence for EVs in community- and hospital-acquired pneumonia.
  • To highlight the potential of EVs in clinical management.

Main Methods:

  • Literature review of clinical and experimental studies.
  • Analysis of evidence for viral and bacterial pneumonia elicitors.
  • Examination of pathogen-specific and overarching mechanisms.

Main Results:

  • Host cell and bacterial EVs are implicated in pneumonia pathogenesis.
  • EVs mediate complex interactions between host and pathogens.
  • Evidence supports the role of EVs in both viral and bacterial pneumonia.

Conclusions:

  • Extracellular vesicles offer promising avenues for pneumonia management.
  • Further research is needed to translate EV potential into clinical applications.
  • EVs could be developed as novel vaccines, biomarkers, or therapeutics.
Keywords:
ARDSBacteriaBiomarkerOuter membrane vesiclesSepsisTherapeuticsVaccineVirus

More Related Videos

Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages08:34

Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages

Published on: February 22, 2017

11.5K
Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions09:36

Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions

Published on: August 26, 2021

4.1K

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.4K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.1K
Intracellular Movement of Viruses and Bacteria01:10

Intracellular Movement of Viruses and Bacteria

Intracellular bacteria and viruses often comprise a group of highly infectious pathogens that can cause several diseases. Bacterial pathogens include those belonging to the genus Rickettsia responsible for conditions such as rocky mountain spotted fever and the Mediterranean spotted fever; Chlamydia, a genus responsible for a sexually transmitted disease; Coxiella burnetii, an agent responsible for Q fever. Viral pathogens include vaccinia—a poxvirus, and herpes simplex virus—a...
3.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
455
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
538
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
358